Clifford Swan Investment Counsel LLC Teva Pharmaceutical Industries LTD Transaction History

Clifford Swan Investment Counsel LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $79,790 - $102,919	-10,100 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$8.61 - $11.04 $24,969 - $32,015	-2,900 Reduced 22.31%	10,100 $97,000
Q3 2020 Oct 30, 2020	SELL	$8.57 - $12.69 $4,285 - $6,345	-500 Reduced 3.7%	13,000 $117,000
Q2 2020 Aug 06, 2020	BUY	$8.12 - $13.12 $4,059 - $6,560	500 Added 3.85%	13,500 $166,000
Q4 2019 Jan 30, 2020	SELL	$6.53 - $10.72 $11,884 - $19,510	-1,820 Reduced 12.28%	13,000 $127,000
Q3 2019 Nov 12, 2019	SELL	$6.16 - $9.6 $652,116 - $1.02 Million	-105,863 Reduced 87.72%	14,820 $102,000
Q2 2019 Aug 13, 2019	BUY	$8.12 - $15.72 $3,004 - $5,816	370 Added 0.31%	120,683 $1.11 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $115,058 - $147,773	-7,385 Reduced 5.78%	120,313 $1.89 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $67,114 - $109,664	-4,600 Reduced 3.48%	127,698 $1.97 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $15,500 - $18,878	-736 Reduced 0.55%	132,298 $2.85 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $64,899 - $95,627	-3,870 Reduced 2.83%	133,034 $3.24 Million
Q1 2018 May 09, 2018	SELL	$16.68 - $22.07 $327,094 - $432,792	-19,610 Reduced 12.53%	136,904 $2.34 Million
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $727,479 - $1.24 Million	-64,780 Reduced 29.27%	156,514 $2.97 Million
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $124,204 - $259,290	-8,060 Reduced 3.51%	221,294 $3.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	229,354	229,354 $7.62 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.